See today's BioWorld
To read the full story, subscribe or sign in.

U.S. FDA approves Octapharma’s blood clotting treatment

July 26, 2023
The U.S. FDA has approved Balfaxar (prothrombin complex concentrate, human-lans) from Octapharma USA Inc.
BioWorld Regulatory U.S.